Details for Patent: 11,065,213
✉ Email this page to a colleague
Which drugs does patent 11,065,213 protect, and when does it expire?
Patent 11,065,213 protects GOCOVRI and is included in one NDA.
This patent has eleven patent family members in nine countries.
Summary for Patent: 11,065,213
| Title: | Amantadine compositions and preparations thereof |
| Abstract: | Provided herein are oral pharmaceutical compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient, and which have a low level of organic solvent. Provided are also methods of orally administrating a composition comprising amantadine, or a pharmaceutically acceptable salt thereof, to a subject, which has reduced gastrointestinal side effects or sleep disturbances. Further provided are extended release oral compositions comprising amantadine, or a pharmaceutically acceptable salt thereof, that are suitable for once daily administration. |
| Inventor(s): | Went; Gregory T. (San Francisco, CA), Fultz; Timothy J. (Big Canoe, GA), Ghosh; Sangita (Foster City, CA), McClure; Natalie (Portola Valley, CA) |
| Assignee: | Adamas Pharma, LLC (Emeryville, CA) |
| Application Number: | 16/677,431 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Device; Dosage form; |
Drugs Protected by US Patent 11,065,213
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Supernus Pharms | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-001 | Aug 24, 2017 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Supernus Pharms | GOCOVRI | amantadine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 208944-002 | Aug 24, 2017 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,065,213
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2018320946 | ⤷ Sign Up | |||
| Brazil | 112020003375 | ⤷ Sign Up | |||
| Canada | 3072764 | ⤷ Sign Up | |||
| China | 111372578 | ⤷ Sign Up | |||
| China | 117860718 | ⤷ Sign Up | |||
| European Patent Office | 3672581 | ⤷ Sign Up | |||
| Israel | 272834 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
